Key points
- Revenue growth of 15.5% with EBIT margin expanding by 43 bps to 10.1%
- Strong performance in both domestic and international segments
- Net Debt to Normalised EBITDA ratio decreased to 0.57x
- Normalised EPS increased by 21.5% with a fully franked final dividend of 2.0 cps
Full summary
Sigma Healthcare Limited reported strong FY26 results, with total group revenue growing by 15.5% and normalized EBIT margin expanding by 43 basis points to 10.1%. The company's domestic network expanded by 24 stores, reaching a total of 561 stores, with like-for-like sales up 13.4%. Internationally, the company opened 20 new stores, bringing the total to 98 stores. The company's net debt to normalized EBITDA ratio decreased to 0.57x, down from 0.85x in the prior year. The company's normalized EPS increased by 21.5%, and the final dividend was 2.0 cps, fully franked, taking the full year dividends to 4.0 cps, representing a 63.0% dividend payout ratio for FY26.
Guidance
Normalized EBIT up 20.6%, EBIT margin growing +43 bps, Revenue growth of 15.5%
Outlook
Sigma Healthcare expects to continue to grow its domestic and international networks, expand its own and exclusive label products, and leverage scale benefits to drive further earnings growth.